Suchergebnisse - "Pozo-Rosich, Patricia"

PubPharm (247)

1

Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment

enthalten in: Medicina clinica | 2024

von Belvís, R. | Irimia, P. | González, N. | +16

2

Dynamic fluctuations of salivary CGRP levels during migraine attacks : association with clinical variables and phenotypic characterization

enthalten in: The journal of headache and pain | 2024

von Alpuente, A. | Gallardo, V. | Asskour, L. | +3

3

Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization

enthalten in: The journal of headache and pain | 2024

von Alpuente, A. | Gallardo, V. | Asskour, L. | +3

4

Reply to the letter : Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S

enthalten in: European journal of neurology | 2024

von Mitsikostas, D. | Caronna, E. | De Tommaso, M. | +11

5

Migraine treatment : quo vadis? Real-world data study (2015-2022) in Spain

enthalten in: BMC neurology | 2024

von Pozo-Rosich, P. | Carmo, M. | Muñiz, A. | +3

6

Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain

enthalten in: BMC neurology | 2024

von Pozo-Rosich, P. | Carmo, M. | Muñiz, A. | +3

7

The state of art on the use of patient reported outcomes in migraine

enthalten in: Current opinion in neurology | 2024

von Alpuente, A. | Torres-Ferrus, M. | Caronna, E. | +1

8

Early Use of Erenumab vs Nonspecific Oral Migraine Preventives : The APPRAISE Randomized Clinical Trial

enthalten in: JAMA neurology | 2024

von Pozo-Rosich, P. | Dolezil, D. | Paemeleire, K. | +10

9

Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE) : a randomised, placebo-controlled, phase 3b trial

enthalten in: The Lancet. Neurology | 2024

von Tassorelli, C. | Nagy, K. | Pozo-Rosich, P. | +7

10

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis

enthalten in: The journal of headache and pain | 2024

von Pozo-Rosich, P. | Poveda, J. | Crespo, C. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]